Fragment-based drug design facilitates selective kinase inhibitor discovery
Zhi-Zheng Wang, Xing-Xing Shi, Guang-Yi Huang, Ge‐Fei Hao, Guang‐Fu Yang
Topics & Concepts
Drug discoveryFragment (logic)DrugPharmacologyKinaseComputational biologyChemistryMedicineComputer scienceBiologyBiochemistryAlgorithmHER2/EGFR in Cancer ResearchComputational Drug Discovery MethodsCancer-related Molecular Pathways